retatrutide approval 2025 status october The FDA has issued warning letters to multiple companies marketing compounded Retatrutide: FDA approval time, trial

It is the only multi-peptide fat-loss stack with Phase 3 data

But its important to see GLP-1s as a springboard, not a destination

Even though its FDA-approved to treat type 2 diabetes, patients in clinical trials also lost around 20% of their weight after a year of taking Mounjaro along with lifestyle changes

PlexusDx also offers the Precision Peptide Genetic Test for $99 after your first month, helping you understand whether your genetics support long-term monotherapy or whether combination approaches like GLP-Squared (semaglutide plus tirzepatide) might better serve your individual response profile

13.7% [press release]